Zobrazeno 1 - 10
of 13 917
pro vyhledávání: '"D Moore"'
Autor:
J Cloete, M Karsas, T Chetty, A Pillay, M Archary, D Moore, T Reddy, Y Balakrishna, F Nakwa, R Lancaster, A Goga, P Jeena
Publikováno v:
South African Medical Journal, Vol 114, Iss 4 (2024)
Antimicrobial resistance (AMR) poses a global threat, partly fueled by antimicrobial overuse. Paediatric inpatients are particularly vulnerable to infections, leading to high antimicrobial consumption. In low-to-middle income countries (LMICs) like S
Externí odkaz:
https://doaj.org/article/c10d251d87b248c7a03708f1fa641bab
Publikováno v:
South African Medical Journal, Vol 108, Iss 8, Pp 667-670 (2018)
Background. Posterior urethral valves (PUV) are a common cause of congenital obstructive nephropathy. The outcome of patients with PUV at Chris Hani Baragwanath Academic Hospital in Johannesburg, South Africa, has not been documented previously.Objec
Externí odkaz:
https://doaj.org/article/f9162a82de434394af6c2d1d65eec204
Publikováno v:
Health Technology Assessment, Vol 17, Iss 33 (2013)
Background: Calcific aortic stenosis (AS) is a common valvular heart disease. Patients with severe symptomatic AS typically survive less than 3 years. In such patients, intervention with surgical aortic valve replacement (SAVR) may increase survival.
Externí odkaz:
https://doaj.org/article/e21c2d37acb54ac0a8d1a2ad12932bda
Autor:
DA Lane, S Raichand, D Moore, M Connock, A Fry-Smith, DA Fitzmaurice, on behalf of the Steering Committee
Publikováno v:
Health Technology Assessment, Vol 17, Iss 30 (2013)
Background: Previous research suggests uncertainty whether or not there is any additional benefit in adding antiplatelet therapy (APT) to anticoagulation therapy (ACT) in patients with high-risk atrial fibrillation (AF) in terms of reduction in vascu
Externí odkaz:
https://doaj.org/article/f2b5774ea6b34df995be3532d92b9ffa
Autor:
K Malottki, P Barton, A Tsourapas, AO Uthman, Z Liu, K Routh, M Connock, P Jobanputra, D Moore, A Fry-Smith, Y-F Chen
Publikováno v:
Health Technology Assessment, Vol 15, Iss 14 (2011)
Background: Rheumatoid arthritis (RA) is an inflammatory condition that typically causes a symmetrical chronic arthritis. Timely use of disease-modifying antirheumatic drugs (DMARDs) is an essential aspect of disease management, but many patients may
Externí odkaz:
https://doaj.org/article/f1aa2754ca94498dbc3d0468df889f02
Publikováno v:
Health Technology Assessment, Vol 14, Iss Suppl 2 (2010)
Externí odkaz:
https://doaj.org/article/ab430151c7f34c0ba62d30064395fd35
Publikováno v:
Health Technology Assessment, Vol 14, Iss Suppl 1 (2010)
Externí odkaz:
https://doaj.org/article/87dbcfffe1314cd9a9a37f9291d2b6e0
Publikováno v:
Health Technology Assessment, Vol 14, Iss Suppl 1 (2010)
Externí odkaz:
https://doaj.org/article/b2311d2825174cc6aad04b818d6b7518
Autor:
Y-F Chen, S Jowett, P Barton, K Malottki, C Hyde, JSR Gibbs, J Pepke-Zaba, A Fry-Smith, J Roberts, D Moore
Publikováno v:
Health Technology Assessment, Vol 13, Iss 49 (2009)
Objective(s): To investigate the clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for the treatment of adults with pulmonary arterial hypertension (PAH) within their licensed indications. Data sources: Ma
Externí odkaz:
https://doaj.org/article/ce233c33a3ef4296a5f3ca18a82f0d21